Tennis Elbow Market, Industry Share, Trends, Growth, Future Prospects, Forecast 2019 to 2025

The global Tennis Elbow Market is growing at a significant CAGR during the forecast period. Tennis elbow (lateral epicondylitis) is a painful condition that arises when tendons of one’s elbow are strained, primarily due to the repeated wrist or arm movements. Tennis elbow pain occurs outside the elbow where the tendons of muscles and bony bumps are connected, this pain can spread to wrist and forearms as well.

Request a Free Sample of our Report on Tennis Elbow Market: https://www.omrglobal.com/request-sample/tennis-elbow-market

The major factors driving the global tennis elbow market is the growing frequency of elbow tendons swelling coupled with rising elbow joints pain incidences. Lateral epicondylitis usually occurs due to the repeated movement of the elbow and legs. Further, there is a rise in cases of tennis elbow in swimmers, plumbers, carpenters, tennis players and basketball players that is expected to propel the market growth in the near future.

Other key factors driving the global Tennis Elbow Market include the rise in healthcare spending and the increasing high-risk geriatric population. This disorder usually occurs as a result of wrist extension against improper equipment handling by the athletes. Individuals over 60 years of age have been found to be more affected by lateral epicondylitis. Thus, over the forecast period, the rapidly growing geriatric population base and the increased incidence of accident-related arm fractures are expected to further fuel the tennis elbow industry.

Moreover, Surgical therapies such as arthroscopy and open surgical procedure are preferred as a final remedy to treat tennis elbow. Technological advancement in the field of surgical equipment and guidance systems is likely to boost market growth. Further, rising preference for minimally invasive procedures owing to benefits such as quicker recovery, improved safety results and minimized blood loss and risk of infection is increasing the demand for arthroscopy for tennis elbow treatment. However, weak development of new efficient therapies in the near future is expected to restrain market growth.

The key market players dominating the global tennis elbow (lateral epicondylitis) market include Pfizer, Inc., Mylan N.V., and GlaxoSmithKline PLC and are providing pain killers and NSAIDS in the market. Whereas, elbow braces manufacturers such as BioSkin, Inc., BraceAbility, Inc., McDavid, Inc. and BTL Corporate are also significantly contributing to the market. The companies are focused on developing advanced legionella testing solutions to stay competitive in the market.

A Full Report of Tennis Elbow Market is Available at https://www.omrglobal.com/industry-reports/tennis-elbow-market

Global Tennis Elbow Market – Segment

By Diagnosis
• X-Rays
• Magnetic Resonance Imaging (MRI) Scan
• Electromyography (EMG)

By Treatment
• Surgical Treatment
o Open surgery
o Arthroscopic surgery

• Non-Surgical Treatment

o Painkiller and NSAIDS
o Corticosteroid Injections
o Shock Wave Therapy
o Equipment and Other

Global Tennis Elbow Market -Region

North America
• United States
• Canada
Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Middle East & Africa
• Latin America

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/tennis-elbow-market

For More Information, Visit https://www.omrglobal.com/

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404

About us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.